Multicentre comparative analysis of long-term outcomes after aortic valve replacement in children
Abstract
The ideal valve substitute for surgical intervention of congenital aortic valve disease in children remains unclear. Data on outcomes beyond 10–15 years after valve replacement are limited but important for evaluating substitute longevity. We aimed to describe up to 25-year death/cardiac transplant by type of valve substitute and assess the potential impact of treatment centre. Our hypothesis was that patients with pulmonic valve autograft would have better survival than mechanical prosthetic.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 05, 2021
- Source ID
- 10.1136/heartjnl-2021-319597
Entities
People
- Amber Leila Sarvestani
- Bahaaldin Alsoufi
- Chizitam Ibezim
- Courtney E Mccracken
- Elizabeth Turk
- Geetha Raghuveer
- James H. Moller
- James St. Louis
- Jessica H Knight
- Lazaros K. Kochilas
Organizations
- National Heart, Lung, and Blood Institute
- United States Department of Defense